Tablets to treat sudden gout flare pain
Treatments studied
Part of Bones, joints & muscles, Genetic & congenital, Hormones & metabolism, Pain clinical trials.
This trial studies dapansutrile tablets (OLT1177) to see how well they work for people in the first 4 days of an acute gout flare. It may help reduce pain and inflammation in the specific joint where your gout is flaring.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have a gout diagnosis, especially in the specific “target” joint
- Your gout flare in the target joint started within the last 96 hours (4 days)
- Your target joint flare is in only a limited number of joints (not 4 or more at once)
- You do not have visible/palpable hard gout lumps (tophi) on exam
- You do not have major kidney problems, active infections in the joint, or other arthritis that could explain the pain
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication, ABP-745, for people having an acute gout flare. It aims to see if the drug is safe and helps reduce pain and inflammation.
This trial tests whether starting dotinurad, a medication that lowers uric acid, at different times after a gout flare begins can help the flare resolve faster. It may help people with frequent or severe gout attacks find quicker relief.
This study tests two doses of a medicine called Purified Cortrophin Gel for people having a gout flare that started in the last 5 days. It might be an option if other treatments haven't worked or aren't safe for you.
This trial tests a combination of two medicines, etoricoxib and betamethasone, for quickly treating a painful gout flare. It is for people who have had gout before and whose current attack started within two days.
This study compares two different treatment goals for a blood level called urate in people with gout. The goal is to see which approach lowers gout flares better while helping people feel better.
This trial tests a new drug called dotinurad for gout patients whose standard medications either don't work or cause side effects. Dotinurad works differently by helping your body get rid of uric acid (the substance that causes gout attacks), and the study will see if it safely lowers uric acid levels.
Hear when a new Gout Flare trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.